EMERYVILLE, Calif. & NEW YORK--(BUSINESS WIRE)--KineMed, Inc., a pathway-based drug discovery and development company, has been awarded a grant of up to $694,441 (if all milestones are met) to conduct clinical studies
For more information, please visit
http://www.businesswire.com/news/home/20090106005335/en